Jennifer Watling Neal, Zachary P. Neal and Brian Brutzman
Brokers, intermediaries and boundary spanners facilitate communication between researchers and practitioners but are these various terms simply different labels for the same role? We spent the last year reviewing published articles in health, education and the environment to explore how each of these terms is defined. In short, we found that, when these terms are used, most of the time they aren’t defined. But, when these terms are defined, there are key differences in what they mean.
There’s increasing recognition that brokers, intermediaries and boundary spanners play a key role in connecting researchers and practitioners. However, inconsistencies in whether and how brokers, intermediaries and boundary spanners are defined make it hard to understand, evaluate and leverage these roles.
What makes experts legitimate in the eyes of policymakers? Even though this is one of the foundational questions of the interdisciplinary scholarship on evidence and policy, the answer is neither straightforward nor simple. Expert legitimacy is driven by seeming contradictions – experts have to be responsive to policymakers’ needs but, at the same time, they cannot be too close to politics. They have to provide advice which is strongly grounded in science but if their advice is too complex it risks being ignored or being perceived too ‘detached’ and ‘academic’. Experts are legitimate when they are insiders and outsiders at the same time. This dynamic has become particularly evident in the ongoing pandemic, where government advisors have had to represent (and at times defend) science whilst at the same time accounting for what policy directions are ‘doable’ – publicly and politically acceptable and economically feasible.
Helen Allbutt and Stewart Irvine
Does research add value? How can we tell? With no mechanism to quality rate research outside of the university sector, research can be overlooked, or worse discontinued, particularly when organisations face ever-increasing pressures. In this blog, we discuss how we sought to protect our research investment by providing an evidence trail of how project findings contributed to strategic priorities. This blog covers the key points of what we did and what we found: for a fuller version, see our Evidence & Policy article, ‘Research assessment in a National Health Service organisation: a process for learning and accountability’.
Rebecca S. Natow
Qualitative research has the potential to be of great value in policymaking. By examining stakeholders’ lived experiences, providing rich detail about policy contexts, and offering nuanced insights about the processes through which programmes are implemented, qualitative research can supply useful information that is not easily, if at all, obtainable through surveys and other quantitative methods. However, policymakers consistently express a preference for quantitative research. This is particularly true for randomised controlled trials (RCTs), which have been called the ‘gold standard’ of evaluation methods.